Du 123015
Latest Information Update: 19 Jan 2007
At a glance
- Originator Solvay
- Class
- Mechanism of Action Serotonin receptor agonists; Serotonin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder
Most Recent Events
- 27 Jul 1999 No-Development-Reported for Anxiety disorders in Belgium (Unknown route)
- 27 Jul 1999 No-Development-Reported for Depression in Belgium (Unknown route)
- 28 Feb 1997 Phase-II clinical trials for Anxiety disorders in Belgium (Unknown route)